MAP2K1 and glioblastoma: Ramaswamy et al. demonstrated that inhibition of the MEK1/2-ERK1/2 pathway led to increased extracellular matrix (ECM)–cell adhesion within the glioblastoma microenvironment with resultant decreased proliferation and migration [107].